Development of BioVie's NE3107 Asset Featured by the American Diabetes Association
June 29, 2021, 3:06 pm
BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and neurodegenerative disorders and certain cancers, announced today that a video documentary detailing the development history of the Company’s newly acquired NE3107 asset will be featured in the American Diabetes Association's Thought Leadership Film Series on ADA TV,
